Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP)
LSE:BXP
Holding GB:BXP?
Track your performance easily
BXP Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range19.33p - 42.00p
Previous Close36.5p
Volume11.55K
Average Volume (3M)61.91K
Market Cap
$37.92B
Enterprise Value45.11B
Total Cash (Recent Filing)$938.65M
Total Debt (Recent Filing)$10.07B
Price to Earnings (P/E)3.9
Beta0.38
Next Earnings
Jan 29, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 22, 2024Dividend Yield5.86%
Share Statistics
EPS (TTM)0.09
Shares Outstanding446,112,089
10 Day Avg. Volume33,359
30 Day Avg. Volume61,913
Standard Deviation0.16
R-Squared0.09
Alpha0.00888
Financial Highlights & Ratios
Price to Book (P/B)0.36
Price to Sales (P/S)1.18
Price to Cash Flow (P/CF)2.90
P/FCF Ratio3.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.21
Enterprise Value/Gross Profit2.61
Enterprise Value/Ebitda6.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Beximco Pharmaceuticals Limited Sponsored GDR RegS News
PremiumCompany Announcements
Beximco Pharma Plans Virtual AGM and RebrandingPremiumCompany Announcements
Beximco Pharmaceuticals Reports Modest Growth Amid Challenges
PremiumCompany Announcements
Beximco Pharma Trading Resumes After Court Victory
PremiumCompany Announcements
Beximco Pharma Temporarily Suspends Trading Amid Legal Uncertainty
PremiumCompany Announcements
Beximco Pharma Reports Strong Financial Growth and Global ExpansionPremiumCompany Announcements
Beximco Pharmaceuticals Reports Strong Profits and Dividend
PremiumCompany Announcements
Beximco Pharma Hearing Adjournment and Rescheduling
PremiumCompany Announcements
Beximco Pharma’s Court Appeal Awaits Full HearingBXP FAQ
What was Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price range in the past 12 months?
Beximco Pharmaceuticals Limited Sponsored GDR RegS lowest share price was 19.32p and its highest was 42.00p in the past 12 months.
What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s market cap?
Currently, no data Available
When is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date is Jan 29, 2025 which is in 38 days.
How were Beximco Pharmaceuticals Limited Sponsored GDR RegS’s earnings last quarter?
Currently, no data Available
Is Beximco Pharmaceuticals Limited Sponsored GDR RegS overvalued?
According to Wall Street analysts Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price is currently Overvalued.
Does Beximco Pharmaceuticals Limited Sponsored GDR RegS pay dividends?
Beximco Pharmaceuticals Limited Sponsored GDR RegS pays a Annually dividend of 2.078p which represents an annual dividend yield of 5.86%. See more information on Beximco Pharmaceuticals Limited Sponsored GDR RegS dividends here
What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beximco Pharmaceuticals Limited Sponsored GDR RegS have?
Beximco Pharmaceuticals Limited Sponsored GDR RegS has 446,112,100 shares outstanding.
What happened to Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Beximco Pharmaceuticals Limited Sponsored GDR RegS?
Currently, no hedge funds are holding shares in GB:BXP
---
Beximco Pharmaceuticals Limited Sponsored GDR RegS Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.90%
12-Months-Change
Fundamentals
Return on Equity
12.86%
Trailing 12-Months
Asset Growth
-14.46%
Trailing 12-Months
Company Description
Beximco Pharmaceuticals Limited Sponsored GDR RegS
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.
---
Technical Analysis
---